| __timestamp | AstraZeneca PLC | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5842000000 | 5903000 |
| Thursday, January 1, 2015 | 4646000000 | 2762000 |
| Friday, January 1, 2016 | 4126000000 | 1114000 |
| Sunday, January 1, 2017 | 4318000000 | 25573000 |
| Monday, January 1, 2018 | 4936000000 | 6000000 |
| Tuesday, January 1, 2019 | 4921000000 | 38845000 |
| Wednesday, January 1, 2020 | 5299000000 | 50523000 |
| Friday, January 1, 2021 | 12437000000 | 75463000 |
| Saturday, January 1, 2022 | 12391000000 | 105767000 |
| Sunday, January 1, 2023 | 8040000000 | 167512000 |
| Monday, January 1, 2024 | 10207000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. AstraZeneca PLC, a global leader, and Xenon Pharmaceuticals Inc., a rising star, offer a fascinating contrast in their cost of revenue from 2014 to 2023. AstraZeneca's expenses peaked in 2021, reaching nearly double their 2014 levels, before slightly declining in 2023. This reflects strategic investments in R&D and production scaling. In contrast, Xenon Pharmaceuticals, with a more modest cost base, saw a staggering 2,700% increase over the same period, highlighting its aggressive growth strategy. By 2023, Xenon's costs were still only about 2% of AstraZeneca's, underscoring the scale difference. This data provides a window into how established giants and emerging innovators navigate financial landscapes, offering insights into their operational priorities and market strategies.
Cost Insights: Breaking Down AstraZeneca PLC and Bristol-Myers Squibb Company's Expenses
Cost of Revenue Comparison: AstraZeneca PLC vs GSK plc
Analyzing Cost of Revenue: AstraZeneca PLC and Supernus Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for AstraZeneca PLC and Travere Therapeutics, Inc.
Cost Insights: Breaking Down AstraZeneca PLC and Evotec SE's Expenses
Cost Insights: Breaking Down AstraZeneca PLC and Xencor, Inc.'s Expenses
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Xenon Pharmaceuticals Inc.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Xenon Pharmaceuticals Inc. vs Galapagos NV
Comparing Cost of Revenue Efficiency: Xenon Pharmaceuticals Inc. vs Viridian Therapeutics, Inc.